GNE Myopathy Clinical Studies at NIH

GNE Myopathy Clinical Studies at NIH

News Releases

September 2012

NIH Launches Trial to Evaluate Drug for Rare Degenerative Muscle Disease Treatment 

New Zealand Pharmaceuticals Ltd Announces a phase I clinical trial using DEX-M74 to treat a rare degenerative muscle disease

June 2007

Mouse Model Points to Possible New Strategy for Treating Rare Muscle Disease, Kidney Disorders

 

Posted: December 14, 2016